SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 27, 2015
MEDICAN ENTERPRISES, INC.
(Exact name of registrant as specified in charter)
Nevada
(State or other jurisdiction of incorporation)
| 000-53408 | | 87-0474017 |
| (Commission File Number) | | (IRS Employer Identification No.) |
| | 3440 E. Russell Road, Las Vegas, NV, 89120 | |
| | (Address of Principal Executive Offices) | |
| | | |
| | (800) 416-8802 | |
| | (Registrant’s Telephone Number, Including Area Code) | |
| | | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Definitive Material Agreement
On April 27, 2015, Medican Enterprises, Inc. (the “Company”) entered into an Agreement for Share Exchange, dated April 27, 2015 (the “Amendment”) with with Twyn Products, Inc. (“TWYN”), wherein the parties agreed to the acquisition of TWYN by the Company in an all-stock transaction valued at approximately $1,000,000.00.
The foregoing summary of the terms of the Agreement is subject to, and qualified in their entirety by, the agreements and instruments attached hereto as Exhibit 10.1, which is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. The following exhibits are filed with this report:
| Exhibit No. | | Description of Exhibit |
| 10.1 | | Agreement for Share Exchange, dated April 27, 2015 between the Company and Twynn Products, Inc. |
| | | |
| | | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | MEDICAN ENTERPRISES, INC. | |
| | | | |
| April 30, 2015 | By: | /s/ Kenneth Williams | |
| | | Kenneth Williams | |
| | | Chief Executive Officer and Director |
| | | |
